Life Sciences Solutions

Palantir Life Sciences Solutions is an AI-powered software platform designed to transform pharmaceutical and life sciences operations across the entire value chain — from drug discovery and clinical development to biomanufacturing and commercial operations. Built on Palantir Foundry and AIP, the platform is purpose-built for life science organizations that require the highest levels of data security and usage governance while needing to accelerate the development and application of new therapies to improve patient outcomes.

By harnessing the latest AI advancements, Palantir enables life sciences companies to generate new insights, automate complex decision-making processes, and drive strategic, scalable impact — all while keeping a human in the loop. Partners including large pharmaceutical companies and clinical research organizations such as Parexel have demonstrated measurable results, including a 50% reduction in submission preparation time and significant improvements in sales performance.

Clinical Development Capabilities

• Site Selection and Feasibility: Empowers feasibility experts to identify optimal clinical trial sites based on site performance, study parameters, and health data.
• Clinical Trial Planning and Design: Unifies public databases, internal sources, and study documents into a single source of truth — the Ontology — to power next-generation trial designs and connect financial data for reporting, analytics, and data-driven operations.
• Generative AI-Enabled Clinical Data Automapping: Deploys generative AI to automate source-to-target mapping of SDTM datasets and clinical data submissions, with a human in the loop to ensure accuracy and traceability.

Commercial Operations Capabilities

• Provider Targeting and Segmentation: Generates insights from unstructured data to cohort providers and optimize sales team interactions with different customer segments.
• AIP-Powered Sales Co-Pilot: Enables sales representatives to use natural language to leverage full customer history and AI-driven insights to customize next best actions for each interaction.
• Tracking and Impact Measurement: Determines sales uplift caused by changes in selling and targeting strategies, enabling continuous performance optimization.
• Medical, Legal, Operational, and Regulatory (MLOR) Review Automation: AIP acts as a review assistant, flagging content issues in real time and recommending solutions to improve content quality and decrease time required for MLOR reviews.

Research and Discovery Capabilities

• Real World Evidence (RWE): Foundry integrates large, disparate RWE sources into a secure environment, enabling democratized data access and analytics to accelerate insights and innovation.
• Connected Lab: Provides a digital twin of the organization to streamline laboratory operations, automate experiment analysis, and enhance collaboration to accelerate scientific discoveries.

Biomanufacturing Capabilities

• Manufacturing and Quality Control: Foundry predicts manufacturing delays so they can be proactively addressed, and leverages automated alerting on material or batch variance, full lineage of inputs, and scenario analysis of inventory routing.
• Quality Assurance and Regulatory Reporting: Automated governance and approval workflows with granular, purpose-based access controls ensure secure and compliant data management.

Demonstrated Partner Outcomes

• Parexel (Clinical Research Organization): Using Palantir AIP, Parexel ingests hundreds of pages of diversified inputs — from PDFs to Excel and text files — into a centralized study Ontology. AI agents automate the production of submission deliverables including tabular datasets, annotated documents, and reproducible code, reducing submission preparation time by over 50% (from 10–12 weeks to 3–4 weeks). AI-driven data mapping and annotation maintain human oversight for any LLM decisions, and earlier access to standardized data accelerates downstream safety trend analysis, signaling, and medical reviews.
• Large Pharmaceutical Company (Commercial Operations): Palantir helped a large pharma company facing declining market share build an AI-powered commercial tool. Results included a 29% increase in sales within four months due to adjusted targeting, a 60% increase in sales when representatives use Palantir, and an 18% improvement in opportunity recovery through AI/ML-enabled loss alerting. Key capabilities deployed included customer segmentation using the Ontology and LLMs, next best campaign determination based on prescribing behavior and campaign history, a sales co-pilot leveraging full customer interaction history, and resource allocation modeling to project downstream sales and cost impacts.

Palantir Life Sciences Solutions is deployed to support the most demanding data security and regulatory compliance requirements in the life sciences industry. The platform integrates across internal and external data sources, supports automated governance workflows, and is designed to scale across the full pharmaceutical value chain — from early-stage research through to patient access and commercial growth.